TinyGemsBreaks Archive - Page 111 of 121

TuesdayJul 26, 2022 10:24 am

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Samsung Mexico SDS Contract Award

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process as well as providing a platform for B2B cross-border shipping in the NAFTA region, has been awarded a contract with Samsung Mexico in regard to its SDS business. According to the announcement, FRGT has already started to use its platform to assist with shipments from Mexico to the United States. Fr8App delivers cross-border capacity “during a difficult market when others have not been able to do so,” said a Samsung Mexico official, who noted that the company has more than 100 trucks going from…

MondayJul 25, 2022 2:29 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Committed to Becoming Prominent International Player in Lidar Space

Cepton (NASDAQ: CPTN) recently opened a newly renovated office in Metro Detroit (Troy, Michigan). The office is intended to enable the company to continue to forge close relationships with automakers centered around the heart of the U.S. auto industry. “Having a strong presence in Detroit not only enables us to keep up with the latest trend in the industry but also makes us part of that trend – we are here to demonstrate how lidar is essential to the future of mobility, with our product experts driving informative communications and our application engineers working in the field,” a recent article…

MondayJul 25, 2022 11:53 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on Phase 2 EB Trial

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis bullosa (“EB”). Based on safety data of the first five adult patients who completed the phase 2 study, an independent data monitoring committee agreed it is safe to allow the enrollment of adolescent patients, defined as persons aged twelve to seventeen with EB. “We are pleased that the initial safety data from InMed’s phase 2 EB clinical trial has allowed…

FridayJul 22, 2022 2:14 pm

TinyGemsBreaks – Why QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’

QSAM Biosciences (OTCQB: QSAM), a clinical-stage biotechnology company, is focused on bringing to market targeted therapeutic radiopharmaceuticals. “The company is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment options for adult and pediatric patients,” a recent article reads. “CycloSam(R), QSAM Biosciences’ initial technology, is a clinical-stage bone targeting radiopharmaceutical invented by world-renowned scientists at IsoTherapeutics Group LLC. … CycloSam is designed to selectively target sites of high bone mineral turnover to deliver a prescribed tumor-killing dose of radiation to the tumor sites while minimizing radiation exposure to nearby healthy tissue. These parameters…

FridayJul 22, 2022 11:59 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) and Colombian Senator Fighting to Legalize Recreational Cannabis Meet

Flora Growth’s (NASDAQ: FLGC) CEO Luis Merchan recently met with Senator Gustavo Bolivar, a Colombian representative who introduced a bill that creates the framework for recreational cannabis in the state. The bill was introduced on July 20, 2022, the same day that Merchan and Bolivar met. The two gentlemen met before Bolivar, a key author of the bill, introduced the bill to Congress. The two talked about what the bill might mean to cannabis countries operating in the country as well as for Colombia’s growing domestic and international cannabis markets, including both domestic trade and international exports. According to the…

ThursdayJul 21, 2022 2:56 pm

TinyGemsBreaks – Golden Matrix Group Inc.’s (NASDAQ: GMGI) GMX-Ag System Facilitating Brand Expansion, Global Market Penetration

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, has been a key beneficiary of a trend that has seen hundreds of gambling platforms opt for white label product offerings from third-party providers. GMGI provides its end customers with access to a substantial portfolio of upwards of 10,000 games. “Golden Matrix Group has looked to cater to growing demand from online gaming platforms, most recently through the launch of its B2B aggregate gaming system, GMX-Ag. The turnkey iGaming system seeks to offer online platforms with an optimal casino, sportsbook and live gaming offering…

ThursdayJul 21, 2022 2:34 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Reminder for Upcoming Annual Shareholder Meeting

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today issued a reminder for its current shareholders regarding the upcoming annual shareholder meeting. Beginning at 9:30 a.m. ET on July 26, 2022, Mullen will conduct a required formal shareholder meeting, which will be followed by a company presentation by David Michery, CEO and chairman of Mullen Automotive. The in-person meeting will be held at the NASDAQ Building, 151 West 42nd Street, 10th Floor (West Cafe – Market Site Event Space), New York, NY 10036. Please note that NASDAQ requires registration (see instructions in press release) for all those planning…

WednesdayJul 20, 2022 2:49 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Unlocking ‘New Frontiers of Discovery’ with Kernel Flow

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various conditions, has announced preliminary data from a feasibility study using Kernel Flow. The results indicate that ketamine-induced changes in functional connectivity last for several days after administration of the substance. “Kernel Flow is the first easy-to-use, wearable device that collects and measures real-time brain activity before, during and after a psychedelic experience. Using the device, the study successfully measured the neuro-effect of ketamine over 11 days, confirming changes in functional connectivity that are consistent with current scientific research,” a recent article reads.…

WednesdayJul 20, 2022 2:41 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Expanding Patient Eligibility in Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced that its global clinical trial for a potentially pivotal brain cancer treatment will expand patient eligibility following an amendment to its protocol for the study. “CNS has been enrolling patients in its phase II clinical trial for novel drug candidate Berubicin, which has shown promise in fighting the aggressive brain cancer glioblastoma (‘GBM’),” explains a recent article. “The trial will compare Berubicin’s performance to the standard of care chemotherapy agent Lomustine, aiming to establish that Berubicin is at least as effective as Lomustine and potentially better because of Berubicin’s reported capacity to cross the…

WednesdayJul 20, 2022 12:59 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Enters Strategic Partnership for Production of Vista(R)-X90 Lidar

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced that it has selected Fabrinet (NYSE: FN), a leading provider of advanced precision optical and electronic manufacturing services, for the production of its Vista(R)-X90 lidar, which will be deployed in the industry’s largest ADAS lidar series production program. According to the update, Cepton selected Fabrinet for its deep expertise in advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services for the production of high-performance, proprietary assemblies of its Vista-X90 lidars. “At Cepton, our goal is to be the world’s go-to supplier of…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks